Unknown

Dataset Information

0

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.


ABSTRACT: Importance:Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited. Objective:To assess patterns of use and relative risks of systemic agents for moderate to severe psoriasis in children. Design, Setting, and Participants:A retrospective review was conducted at 20 centers in North America and Europe, and included all consecutive children with moderate to severe psoriasis who used systemic medications or phototherapy for at least 3 months from December 1, 1990, to September 16, 2014. Main Outcomes and Measures:The minimal core data set included age, sex, severity of psoriasis, systemic interventions, monitoring, adverse events (AEs), and reason for discontinuation. Results:For 390 children (203 girls and 187 boys; mean [SD] age at diagnosis, 8.4 [3.7] years) with psoriasis who used 1 or more systemic medications, the mean interval between diagnosis and starting systemic therapy was 3.0 years. Methotrexate was used by 270 patients (69.2%), biologic agents (primarily etanercept) by 106 (27.2%), acitretin by 57 (14.6%), cyclosporine by 30 (7.7%), fumaric acid esters by 19 (4.9%), and more than 1 medication was used by 73 (18.7%). Of 270 children taking methotrexate, 130 (48.1%) reported 1 or more AEs associated with methotrexate, primarily gastrointestinal (67 [24.8%]). Folic acid 6 days per week (odds ratio, 0.16; 95% CI, 0.06-0.41; P?

SUBMITTER: Bronckers IMGJ 

PROVIDER: S-EPMC5710436 | biostudies-other | 2017 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications


<h4>Importance</h4>Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited.<h4>Objective</h4>To assess patterns of use and relative risks of systemic agents for moderate to severe psoriasis in children.<h4>Design, setting, and participants</h4>A retrospective review was conducted at 20 centers in North America and Europe, and included all consecutive children with moderate to severe psoriasis who used syst  ...[more]

Similar Datasets

| S-EPMC9446895 | biostudies-literature
| S-EPMC10407342 | biostudies-literature
| S-EPMC10561476 | biostudies-literature
| S-EPMC5697570 | biostudies-literature
| S-EPMC10210163 | biostudies-literature
| S-EPMC7042803 | biostudies-literature
| S-EPMC8393839 | biostudies-literature
| S-EPMC8750137 | biostudies-literature
| S-EPMC9796396 | biostudies-literature
| S-EPMC9055370 | biostudies-literature